BMS-639432

TypeName: Business Offer
Category:
Offer Date:2019/08/10
Country: United States
Summary: BMS-639432 is an impurity of Dapagliflozin, a sodium-glucose co-transporter type 2 (SGLT2) inhibitor developed for the treatment of type 2 diabetes mellitus (T2DM). https://www.bocsci.com/bms-639432-cas-1204222-85-4-item-475145.html
Description:
OfferId: 5139
Name:Alex Brown
Telphone:
Categories